NCT00912054View on ClinicalTrials.gov

DuoTrav APS Versus XALACOM® in Ocular Surface Health

PHASE3TerminatedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Open Angle GlaucomaOcular Hypertension
Interventions
DRUG

DuoTrav APS

travoprost APS 40 micrograms/ml / timolol 5 mg/ml, Eye Drops, Solution, once daily

DRUG

Xalacom

XALACOM® (latanoprost 50 micrograms/ml / timolol 5 mg/ml) Eye Drops, Solution

Trial Locations (1)

Unknown

Cliniques Universitaires Saint Luc, Brussels

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY